A Review on Chronic Obstructive Pulmonary Disease

  • Posted on: 10 February 2014
  • By: admin

Pharma Admission

Pharma courses

pharma admission

pharma courses


PharmaTutor (February- 2014)
ISSN: 2347 - 7881


Received On: 02/01/2014; Accepted On: 10/01/2014; Published On: 10/02/2014


Author: 1Rashmi Verma, 2Rakesh Tiwle
1Department of Pharmaceutics,
 Rungta College of Pharmaceutical Sciences & Research, Bhilai, 491024, C.G
2Shri Laxmanrao Maker Institute of Pharmacy, Amgaon, Gondia,
Maharashtra, India- 441902.


ABSTRACT: In the ancient age COPD has a variable natural history and not all individuals follow the same course about 15-20% of smokers develop clinically significant COPD. It is characterized by the airflow obstruction that is not fully reversible. It is predominantly caused by smoking, particularly occupational exposures,may also contribute to the development of COPD.Chronic obstructive pulmonary disease is diagnosed using a medical device called a spirometer, which measures air volume and flow, the main components of common clinical breathing tests (pulmonary function tests).  Long-term exposure to lung irritants that damage the lungs and the airways usually is the cause of COPD. In this article we are focus about and detail review on the COPD.


How to cite this article: R Verma, R Tiwle, A Review on Chronic Obstructive Pulmonary Disease, PharmaTutor, 2014, 2(2), 98-110